Public-registry site landscape for NCT07738107, a Cardiac Glycogenosis study sponsored by Atrium Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07738107 (registry record) |
| Sponsor | Atrium Therapeutics |
| Condition(s) | Cardiac Glycogenosis; Cardiomyopathy; Hypertrophic; Wolff-Parkinson-White Syndrome |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 0 |
Eichor generates a preliminary site-risk snapshot for NCT07738107 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →